Anthropic (Claude) May Be the Only $1 Trillion IPO Worth Buying

Anthropic has confidentially filed for an IPO after raising $65 billion at a $965 billion post-money valuation, overtaking OpenAI’s $852 billion private valuation. Media reports suggest Anthropic may reach a nearly $50 billion annualized revenue run rate by end-June and could turn operating profitable this quarter, making a potential $1 trillion IPO look more achievable than OpenAI’s. The article is largely speculative but highlights strong investor appetite for AI listings and sizable implied first-day valuations.

Analysis

The immediate market read is not “another giant IPO,” but a re-rating of the AI capital hierarchy: the premium is shifting from model share to capital efficiency and monetization quality. If one frontier lab can credibly approach breakeven while scaling faster than peers, the market will start penalizing the rest of the stack for excessive compute commitments and weak operating leverage. That is constructive for infrastructure suppliers in the near term, but only selectively — investors will likely favor the vendors tied to the most efficient spenders, not the ones exposed to indiscriminate capex growth.

For NVDA, the second-order effect is nuanced: a profitable, faster-growing entrant strengthens the narrative that AI demand is still under-supplied, but it also raises the bar for every customer’s ROI scrutiny. Over the next 1-2 quarters, the market may rotate toward “best unit economics” AI beneficiaries and away from any AI beneficiary whose revenue is highly leveraged to frontier model capex. INTC’s relevance is more indirect: if the market starts rewarding inference efficiency and lower-cost deployment, the conversation shifts toward alternative compute architectures, edge inference, and custom silicon, which is a better strategic backdrop than pure training spend.

The real catalyst path is the filing itself: once the S-1 lands, the market will immediately test whether public investors are willing to underwrite hypergrowth with an actual path to operating profit. If guidance implies falling gross margins or a heavy step-up in opex, the valuation premium can compress quickly even if top-line growth remains strong. Conversely, a clean path to profitability would be a powerful signal that the private market’s AI enthusiasm is not just multiple inflation, but a genuine market structure change.

Key Decisions for Investors

• Stay long NVDA, but prefer a call spread over outright stock into the S-1 window: 1-3 month upside is still intact if the filing confirms strong enterprise demand, but valuation sensitivity rises if the market starts questioning AI capex ROI.
• Initiate a relative-value pair: long INTC / short a basket of high-beta AI infrastructure names most exposed to indiscriminate model training spend, on the thesis that the market will reward cost-efficient inference and alternative compute paths over the next 3-6 months.
• Use any post-filing gap-up in AI ecosystem names to fade momentum via short-dated call overwrites or put spreads; the risk/reward improves if the IPO narrative becomes a sell-the-news event after the registration statement clarifies unit economics.
• If the S-1 shows credible operating leverage, buy 3-6 month upside exposure in NVDA on pullbacks rather than strength — the better setup is a confirmation dip, not chasing pre-event optimism.
• Treat NDAQ as a medium-horizon beneficiary of a reopened IPO market, but size it modestly; the catalyst is months away and depends on a broader issuance cycle, not this one deal.